Rankings · Price against the business

A-graded, furthest below their high

Graded A, ranked by how far the share price sits below its 52-week high. The grade is built from the filings alone; the fall is a fact about the price, not the business.

68 companies meet this test

Figures as of November 15, 2026

#CompanyGradeBelow 52-week highP/EMarket value
1VCYTVERACYTE, INC.A+-60%15.80$2B
2NRIXNURIX THERAPEUTICS, INC.A+-44%6.73$1.7B
3CORTCORCEPT THERAPEUTICS INCA+-41%57.43$8B
4LQDALIQUIDIA CORPORATIONA-37%—$5.2B
5CAICARIS LIFE SCIENCES, INC.A-36%13.88$6.6B
6BLLNBillionToOne, Inc.A-30%114.29$5B
7ILMNIllumina, Inc.A+-30%35.63$31.3B
8ISRGIntuitive Surgical, Inc.A+-25%53.70$153.8B
9HALOHALOZYME THERAPEUTICS, INC.A+-24%25.01$11.4B
10INNVInnovAge Holding Corp.A-22%157.83$1.3B

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.